Jacob Hughes
Stock Analyst at Wells Fargo
(1.34)
# 3,410
Out of 4,876 analysts
27
Total ratings
50%
Success rate
-1.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jacob Hughes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $23.08 | +90.64% | 5 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $26.54 | +103.47% | 1 | Sep 6, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $0.73 | +1,678.63% | 3 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $19.28 | +190.46% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $6.35 | +498.43% | 3 | May 4, 2022 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Equal-Weight | $12 → $11 | $16.76 | -34.37% | 11 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $18 → $17 | $6.46 | +163.16% | 3 | Oct 28, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $23.08
Upside: +90.64%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $26.54
Upside: +103.47%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $0.73
Upside: +1,678.63%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $19.28
Upside: +190.46%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $6.35
Upside: +498.43%
Teva Pharmaceutical Industries
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $12 → $11
Current: $16.76
Upside: -34.37%
Bausch Health Companies
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $18 → $17
Current: $6.46
Upside: +163.16%